|
|
LATISSE® (bimatoprost
ophthalmic solution) 0.03%
approved by the U.S. Food and Drug Administration (FDA) in 2008, is a
novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis
is another name for having inadequate or not enough eyelashes. LATISSE® is
the first and only FDA-approved, science-based treatment to enhance
eyelash prominence as measured by increases in length, thickness and
darkness of eyelashes.
Available only through a doctor, LATISSE® is a once-daily prescription
treatment applied to the base of the upper eyelashes with a sterile,
single-use-per-eye disposable applicator. LATISSE® users can expect to
experience longer, fuller and darker eyelashes in as little as eight
weeks, with full results in 16 weeks. To maintain effect, continued
treatment with LATISSE® is required. If use of LATISSE® is discontinued,
eyelashes will gradually return to where they were prior to treatment over
a period of weeks to months (average eyelash hair cycle). Ask your doctor
if LATISSE® is right for you.
|